Document is current

Any future updates will be listed below

Neues Biosimilar für die Rheumatherapie verfügbar

Crossref DOI link: https://doi.org/10.1007/s15006-018-1185-6

Published Online: 2018-11-26

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark